Will we ever see through the fog in the DePuy ASR case? Internal emails now suggest product performance was a consideration in stopping the PMA and ultimate product withdrawal.
DePuy Orthopaedics unveils advancements in orthopaedic treatment at AAOS. Focus is on Clinical and Economic Value, Procedural Efficiency, Personalization.
UK MHRA updates all-metal hip guidance with statement that most patients are at low risk of developing any serious problems.
Northwestern University has issued a press release about recent work published in December in Science relating to the formation of graphitic carbon, which has been identified as a naturally forming lubricant in metal-on-metal bearing surfaces in hip prostheses.
DePuy Spine, Inc. announced the launch of HEALOS® Fx Injectable Bone Graft Replacement (HEALOS Fx), the company’s first bone graft solution designed specifically for minimally invasive spine surgery (MIS).